Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000253057 | SCV000192803 | benign | not specified | 2020-10-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000253057 | SCV000313001 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000726423 | SCV000344524 | uncertain significance | not provided | 2016-08-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000145695 | SCV000562428 | benign | CHARGE syndrome | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726423 | SCV001960360 | benign | not provided | 2020-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002408646 | SCV002669290 | likely benign | Inborn genetic diseases | 2018-01-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |